The global Chagas disease treatment market is expected to grow at a significant CAGR during the forecast period (2021-2027). Chagas disease is a parasitic infection caused by Trypanosoma cruzi, a protozoan parasite. It is one of the NPIs(Neglected Parasitic Infection) in the US. This disease has been targeted by the Centers for Disease Control and Prevention for community health action. The market is growing owing to an increase in the number of people living with the disease. The number of people suffering from Chagas disease is rising across the globe. As per the CDC, nearly 7 million people are infected by the parasite that causes Chagas disease. Although the parasite is found only in the Americas.  As per the CDC, more than 300,000 people are living with the disease in the US and it causes 10,000 mortality each year globally.  The factors driving the market growth include increased spending on healthcare infrastructure and an increase in demand for disease-specific innovative medications and treatments. In addition, the increasing consumption of undercooked food contaminated with faeces may also cause Chagas disease, which is driving the adoption of treatment for Chagas disease. 

Several competitors in the global Chagas disease treatment market have been boosting their R&D efforts to introduce new products and stay competitive in the marketplace. Furthermore, increasing initiatives by government and private organizations to create awareness among the people about the disease is contributing to the growth of the market. For instance, the international humanitarian organization, Médecins Sans Frontières/Doctors Without Borders (MSF) initiated a campaign in April 2018. The campaign aimed to raise public awareness about Chagas disease, which is still widespread in Latin American countries and affects around 6 million people across the globe. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Bayer AG, GlaxoSmithKline plc, and Novartis International AG, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Chagas Disease Treatment Market Report by Segment

By Treatment 

• Antiparasitic Treatment 

• Symptomatic Treatment

By Drug Type 

• Benznidazole

• Nifurtimox

By Distribution Channel

• Hospitals Pharmacies 

• Retail Pharmacies

• Online Pharmacies

Global Chagas Disease Treatment Market by Region